EP Biocomposites Reports H1 FY27 Results and Annual Outlook
EP Biocomposites Ltd · Financial Result · 13 Nov 2026, 11:31 pm
EP Biocomposites Reports H1 FY27 Results and Annual Outlook For the half-year ended 30th Sep'26, EP Biocomposites reported revenue from operations of ₹295.38 lakhs, down 27.5% YoY from ₹407.48 lakhs, and recorded its first post-listing net loss of ₹43.40 lakhs versus a ₹9.04 lakhs profit in H1 FY26. Diluted EPS stood at -₹2.58. Higher employee expenses for expansion impacted profitability. Despite the weak first half, management expects full-year revenue to reach approximately ₹16.00 crore (>15% YoY growth), supported by ₹5.74 crore in orders in hand and ₹7.00 crore in expected orders.
Original exchange filing (PDF)
More announcements from EP Biocomposites Ltd
- Financial results for the half year ended September 30, 2026 along with the management commentary · 13 Nov 2026
- EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Half yearly results for the .... · 06 Nov 2026
- Scrutinizer''s Report for the 7th Annual General Meeting · 30 Sept 2026
- Intimation of Strategic Collaboration and Consultancy Agreement entered with Malligavad Foundation and Anand Malligavad · 29 Sept 2026
- Proceedings of the seventh annual general meeting of the Company · 29 Sept 2026
- Intimation for award of order for 70KLD STP unit · 27 Sept 2026
- Chairman''s speech proposed to be delivered in the upcoming annual general meeting · 26 Sept 2026
- Presentation prepared for the upcoming annual general meeting and upcoming investor meet, if any · 21 Sept 2026
